Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 16;58(11):1658.
doi: 10.3390/medicina58111658.

The Relationship between Nrf2 and HO-1 with the Severity of COVID-19 Disease

Affiliations

The Relationship between Nrf2 and HO-1 with the Severity of COVID-19 Disease

Damir Mihić et al. Medicina (Kaunas). .

Abstract

Nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) have significant roles in the development of a hyperinflammatory state in infectious diseases. We aimed to investigate the association of the serum concentrations of Nrf2 and HO-1 with the severity of COVID-19 disease. The study included 40 subjects with mild and moderately severe forms of the disease (MEWS scoring system ≤2). Twenty of the subjects had MEWS scores of 3 or 4, which indicate a severe form of the disease, and twenty subjects had a MEWS score of ≥5, which indicates a critical form of the disease. HO-1 and Nrf2 were measured using the commercially available Enzyme-Linked Immunosorbent Assay (ELISA). Subjects with the most severe form of COVID-19 (critically ill) had a lower concentration of Nrf2 that negatively correlated with the markers of hyperinflammatory response (CRP, IL-6, ferritin). This observation was not made for HO-1, and the correlation between Nrf2 and HO-1 values was not established. In the mild/moderate form of COVID-19 disease, Nrf2 was associated with an increased 1,25 dihydroxy vitamin D concentration. The results of this study show that Nrf2 has a role in the body's anti-inflammatory response to COVID-19 disease, which makes it a potential therapeutic target.

Keywords: COVID-19; NF-E2-related factor 2 (Nrf2); heme oxygenase-1 (HO-1).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Serum concentrations of Nrf2 (A) and HO-1 (B) in patients with COVID-19 disease. *** p < 0.05.

References

    1. Attaway A.H., Scheraga R.G., Bhimraj A., Biehl M., Hatipoğlu U. Severe COVID-19 pneumonia: Pathogenesis and clinical management. BMJ. 2021;10:372. doi: 10.1136/bmj.n436. - DOI - PubMed
    1. Khan M., Adil S.F., Alkhathlan H.Z., Tahir M.N., Saif S., Khan M., Khan S.T. COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules. 2020;26:39. doi: 10.3390/molecules26010039. - DOI - PMC - PubMed
    1. Ciceri F., Castagna A., Rovere-Querini P., De Cobelli F., Ruggeri A., Galli L., Conte C., De Lorenzo R., Poli A., Ambrosio A., et al. Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy. Clin. Immunol. 2020;217:108509. doi: 10.1016/j.clim.2020.108509. - DOI - PMC - PubMed
    1. Pascarella G., Strumia A., Piliego C., Bruno F., Del Buono R., Costa F., Scarlata S., Agrò F.E. COVID-19 diagnosis and management: A comprehensive review. J. Intern. Med. 2020;288:192–206. doi: 10.1111/joim.13091. - DOI - PMC - PubMed
    1. Petrey A.C., Qeadan F., Middleton E.A., Pinchuk I.V., Campbell R.A., Beswick E.J. Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex. J. Leukoc. Biol. 2021;109:55–66. doi: 10.1002/JLB.3COVA0820-410RRR. - DOI - PMC - PubMed